-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Eloxx Pharma with Buy Rating, Announces Price Target of $43

Benzinga·07/20/2026 12:02:14
语音播报
Guggenheim analyst Vamil Divan initiates coverage on Eloxx Pharma (NASDAQ:ELOX) with a Buy rating and announces Price Target of $43.